²é¿´: 565  |  »Ø¸´: 2
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yolanda1234

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÃÀ¹úµÄÒ»¸öÐÂҩרÀû

±¾ÈËÔÚÉúÎï¹ÈÖп´µ½Ò»ÔòÏûÏ¢£¬Ô­ÎÄΪ£º2013Äê3ÔÂ5ÈÕѶ /ÉúÎï¹ÈBIOON/ --ÎäÌTakeda£©ÓëÃÀ¹úÉúÎï¼¼Êõ¹«Ë¾Resolve Therapeutics´ï³ÉÁ˺Ï×÷»ï°é¹ØÏµ£¬¹²Í¬¿ª·¢»¯ºÏÎÓÃÓÚÖÎÁƺì°ßÀÇ´¯¼°ÆäËû×ÔÉíÃâÒßÐÔ¼²²¡¡£Ïȵ¼»¯ºÏÎïRSLV-132ÊÇÒ»ÖÖºËøFcÈںϵ°°×£¬Äܹ»½µ½â²¢Çå³ýº¬ÓÐ×ÔÉí¿¹ÌåµÄÃâÒ߸´ºÏÎ˫·½½«ÔÚ½ñÄêÍíЩʱÆÚÆô¶¯¸Ã»¯ºÏÎïµÄÁÙ´²¿ª·¢¡£´ËÍ⣬»¹ÓÐÊýÖÖ»¯ºÏÎï´¦ÓÚÁÙ´²Ç°µÄ¸ÅÄîÑéÖ¤½×¶Î¡££¨ÉúÎï¹Èbioon.com£©
ÏêϸӢÎı¨µÀ£º
The lead compound, RSLV-132, is a nuclease Fc fusion protein that degrades and eliminates autoantibody-containing immune complexes, which are thought to be the most proximal pathophysiological trigger of lupus. It will begin clinical development later this year. Additional Resolve clinical candidates are in the pre-clinical proof-of-concept stage.
Resolve will conduct all development work under the collaboration until completion of the first RSLV-132 Phase 1b/2a trial in lupus patients. Takeda has the exclusive option to license the lead compound and all other compounds from the Resolve platform upon the completion of the Phase 1b/2a trial. Upon exercise of its option, Takeda would assume lead responsibility for worldwide development and commercialization of the Resolve products.
Under the terms of the agreement, Takeda will help fund continued development of RSLV-132 through an initial payment of US$8 million to Resolve in fiscal 2012. Upon exercise of its option, Takeda would pay Resolve an option exercise fee, plus the potential for additional development milestones totaling US$247 million. Furthermore Resolve is eligible to receive royalties on product sales.
¹Ø¼ü´Ê£º ÎäÌï ºì°ßÀÇ´¯
ÇóÕâ¸öRSLV-132µÄרÀûÔ­ÎÄ¡£¡£¡£¡£¡£¡£¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÐÂÊÖÉÏ·£¬Ð¡Ä¾³æ£¬ÎҵĿÆÑаéÂÂ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jinlong3820

½ð³æ (ÖøÃûдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by wjswift at 2013-03-08 11:52:38
US20120225066
CN102770533
http://1000eb.com/gksl

¸Ð¾õlzÇóÖúµÄ¶«Î÷ºÍÌîµÄרҵ²»´î°¡£¬ÕæÊÇÉæÁԹ㷺¡£¡£¡£

²»ÓÃÄÇôÔÚÒâµÄ£¬Ëæ±ãд¸ö¾ÍºÃÁË£¬Äú¾õµÃÁË£¿
Stayhungry£¬stayfoolish£¡Ò»¸ö²»ÖªµÀºó»ÚµÄ±¿µ°|| ƽµ­ÖиøÄ㾪ϲ£¡
3Â¥2013-03-09 10:37:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 3 ¸ö»Ø´ð

wjswift

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¿´ÎÄÏ×£¬×öʵÑé......

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
yolanda1234: ½ð±Ò+30, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÆäʵÊÇÎÒÏëÖªµÀÕâ¸ö¿ìѶÊÇ·ñÊÇÕæµÄ£¬Ð»Ð»Ä㣬Õâô¿ì¾Í¸øÎһظ´ÁË¡£»¹ÓÐÎÊÌâÏëÎÊÂ¥Ö÷Ŷ¡£Õâ¸öÒ©£¬Èç¹ûͶÈëÊг¡»¹Òª¶à¾Ã£¿ 2013-03-08 17:17:08
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2013-03-09 08:01:27
US20120225066
CN102770533
http://1000eb.com/gksl

¸Ð¾õlzÇóÖúµÄ¶«Î÷ºÍÌîµÄרҵ²»´î°¡£¬ÕæÊÇÉæÁԹ㷺¡£¡£¡£
Darwin said, a scientific man ought to have no wishes, no affections, - a mere heart of stone.
2Â¥2013-03-08 11:52:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁÏ305·ÖÇóµ÷¼Á +6 ÏëÉϰ¶µÄÀðÓã 2026-03-18 7/350 2026-03-21 01:03 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸ Î÷±±´óѧ £¬070300»¯Ñ§Ñ§Ë¶£¬×Ü·Ö287£¬Ë«·ÇÒ»±¾£¬Çóµ÷¼Á¡£ +3 ³¿»èÏßÓëÐǺ£ 2026-03-18 3/150 2026-03-21 00:46 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖØÇì´óѧ085700×ÊÔ´Óë»·¾³×¨Ë¶£¬×Ü·Ö308Çóµ÷¼Á +3 īīĮ 2026-03-18 3/150 2026-03-21 00:39 by JourneyLucky
[¿¼ÑÐ] 311Çóµ÷¼Á +5 ¶¬Ê®Èý 2026-03-18 5/250 2026-03-21 00:16 by JourneyLucky
[¿¼ÑÐ] 323Çóµ÷¼Á +3 ÍÝСͰ 2026-03-18 3/150 2026-03-20 22:54 by JourneyLucky
[¿¼ÑÐ] 350Çóµ÷¼Á +5 weudhdk 2026-03-19 5/250 2026-03-20 22:04 by luoyongfeng
[¿¼ÑÐ] 290Çóµ÷¼Á +7 ^O^Ø¿ 2026-03-19 7/350 2026-03-20 21:43 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»Í¨ ר˶ ²ÄÁÏ355 ±¾¿ÆË«·Ç Çóµ÷¼Á +5 Î÷ÄϽ»Í¨×¨²Ä355 2026-03-19 5/250 2026-03-20 21:10 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì348Çóµ÷¼Á +3 £þ^£þ©bº¹ 2026-03-19 4/200 2026-03-20 21:01 by zhukairuo
[¿¼ÑÐ] »·¾³¹¤³Ìµ÷¼Á +9 ´ó¿Édigkids 2026-03-16 9/450 2026-03-20 17:38 by ×íÔÚ·çÀï
[¿¼ÑÐ] 286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡ +3 lemonzzn 2026-03-17 4/200 2026-03-20 11:04 by lemonzzn
[¿¼ÑÐ] ÄÜÔ´²ÄÁÏ»¯Ñ§¿ÎÌâ×éÕÐÊÕ˶ʿÑо¿Éú8-10Ãû +5 ÍÑÓ±¶ø³ö 2026-03-16 14/700 2026-03-20 09:30 by kkcoco25
[¿¼ÑÐ] »¯Ñ§Çóµ÷¼Á +3 ÁÙÔó¾³llllll 2026-03-17 4/200 2026-03-19 13:59 by houyaoxu
[¿¼ÑÐ] 312Çóµ÷¼Á +8 İå·Ï£ 2026-03-16 9/450 2026-03-18 12:39 by Linda Hu
[¿¼ÑÐ] ²ÄÁÏ£¬·ÄÖ¯£¬ÉúÎ0856¡¢0710£©£¬»¯Ñ§ÕÐÉúÀ² +3 Eember. 2026-03-17 9/450 2026-03-18 10:28 by Eember.
[¿¼ÑÐ] 326Çóµ÷¼Á +5 Éϰ¶µÄСÆÏ 2026-03-15 6/300 2026-03-17 17:26 by ruiyingmiao
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] [µ¼Ê¦ÍƼö]Î÷ÄϿƼ¼´óѧ¹ú·À/²ÄÁϵ¼Ê¦ÍƼö +3 ¼â½ÇСºÉ 2026-03-16 6/300 2026-03-16 23:21 by ¼â½ÇСºÉ
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] Öпƴó²ÄÁÏÓ뻯¹¤319Çóµ÷¼Á +3 ÃÏöβÄÁÏ 2026-03-14 3/150 2026-03-14 20:10 by ms629
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û